Literature DB >> 6981600

An influenza specific T-killer clone is restricted to H-2Ld and cross-reacts with Dk region.

B A Askonas, Y L Lin.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6981600     DOI： 10.1007/BF00364444

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  16 in total

1.  Fine specificity of a continuously growing killer cell clone specific for H-Y antigen.

Authors:  H von Boehmer; H Hengartner; M Nabholz; W Lernhardt; M H Schreier; W Haas
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

2.  Direct cloning and extended culture of antigen-specific MHC-restricted, proliferating T lymphocytes.

Authors:  B Sredni; H Y Tse; R H Schwartz
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

Review 3.  Molecular heterogeneity of H-2 antigens.

Authors:  P Démant; D Iványi; M Oudshoorn-Snoek; J Calafat; M H Roos
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Primary structural studies of an H-2L molecule confirm that it is a unique gene product with homology to H-2K and H-2D antigens.

Authors:  J E Coligan; T J Kindt; R Nairn; S G Nathenson; D H Sachs; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

5.  Alloantigens determined by a second D region locus elicit a strong in vitro cytotoxic response.

Authors:  T H Hansen; R B Levy
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Functional heterogeneity of H-2Dk-region products.

Authors:  P Démant; D Iványi; K Fischer-Lindahl
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap.

Authors:  C J Hackett; B A Askonas
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

8.  Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis.

Authors:  T R Hünig; M J Bevan
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

9.  Involvement of H-2L gene products in virus-immune T-cell recognition. Evidence for an H-2L-restricted T-cell response.

Authors:  W E Biddison; T H Hansen; R B Levy; P C Doherty
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes.

Authors:  T J Braciale; M E Andrew; V L Braciale
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307
View more
  6 in total

1.  Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Alan L Rothman; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-02-26       Impact factor: 3.641

2.  Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivities.

Authors:  D C Wraith
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer.

Authors:  C S Reiss; G A Evans; D H Margulies; J G Seidman; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

4.  Diversity in the interaction of influenza-A-specific cytotoxic T cells with H-2Kb mutant targets.

Authors:  A R Townsend; P M Taylor; C J Melief; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  The H-2dm1 mutation and Qa antigens.

Authors:  P M Hogarth; I D Walker; A J Rigby; I F McKenzie
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Karin M Green; James Potts; Anita M Leporati; Jenny Aurielle B Babon; James E Evans; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-10-31       Impact factor: 3.641
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.